Has the Drug GRN-29 Improved Autism Symptoms in Mice?
Question by Kevin7: has the drug GRN-29 improved autism symptoms in mice?
science daily news
Best answer:
Answer by H????? ?oi 416™
*GRN-529
Agent Reduces Autism-Like Behaviors in Mice: Boosts Sociability, Quells Repetitiveness
ScienceDaily (Apr. 25, 2012) — National Institutes… Continue reading
Molecular Distribution of Amino Acid Substitutions on Neuraminidase From the 2009 (H1N1) Human Influenza Pandemic Virus.
Molecular distribution of amino acid substitutions on neuraminidase from the 2009 (H1N1) human influenza pandemic virus.
Bioinformation. 2013; 9(13): 673-9
Quiliano M, Valdivia-Olarte H, Olivares C, Requena D, Gutiérrez AH, Reyes-Loyola P, Tolentino-Lopez LE, Sheen P, Briz V, Muñoz-Fernández… Continue reading
Poisoning With Depilatory Agents in Iran.
Poisoning with depilatory agents in Iran.
J Res Med Sci. 2013 Feb; 18(2): 168-9
Mehrpour O, Farzaneh E, Hasanian-Moghaddam H, Abdollahi A, Rayesson MR, Abdollahi M
Addiction is a Reward Deficit and Stress Surfeit Disorder.
Unintentional Weakness of Cancers: The MEK/ERK Pathway as a Double-Edged Sword.
Unintentional weakness of cancers: the MEK/ERK pathway as a double-edged sword.
Mol Cancer Res. 2013 Jul 30;
Suda K, Mitsudomi T
Recent advances in molecular target therapy have greatly improved treatment outcomes for cancers driven by oncogenic mutations. However… Continue reading
Mechanisms of Resistance to Sorafenib and the Corresponding Strategies in Hepatocellular Carcinoma.
Mechanisms of resistance to sorafenib and the corresponding strategies in hepatocellular carcinoma.
World J Hepatol. 2013 Jul 27; 5(7): 345-52
Zhai B, Sun XY
Sorafenib, the unique drug as first-line treatment for advanced hepatocellular carcinoma (HCC), has opened a… Continue reading
The Pharmacists’ Potential to Provide Targets for Interventions to Optimize Pharmacotherapy in Patients With Asthma.
The pharmacists’ potential to provide targets for interventions to optimize pharmacotherapy in patients with asthma.
Int J Clin Pharm. 2013 Jul 26;
van Boven JF, Hiddink EG, Stuurman-Bieze AG, Schuiling-Veninga CC, Postma MJ, Vegter S
Background Despite of pharmacists’ specialized knowledge of medication and his/her regular contact with patients, the expertise of the pharmacist may not be used enough yet. Furthermore, the potential of pharmacy dispensing data is underestimated. Objective To provide targets for tailored interventions in asthma patients and to illustrate the potential value of pharmacists in the identification of these targets using individual pharmacy dispensing data. Setting We performed a cross sectional retrospective analysis assessing the quality of asthma patients’ pharmacotherapeutic treatment. Method Drug dispensing data from 2008 to 2009 were retrieved from a Dutch pharmacy database. All asthma patients were screened for potential suboptimal pharmacotherapy in 2009. Results were projected to a single community pharmacy to provide an estimate of the number of patients eligible for potential interventions. Main outcome measures (1) frequent use of short-acting ?-agonists without preventive medication, (2) concomitant use of ?-blockers, (3) multiple short courses of oral corticosteroids without using inhaled corticosteroids and 4) use of long-acting ?-agonist without inhaled corticosteroids. Results A total of 8,504 patients were eligible for analysis of the quality of their asthma treatment. 20.9 % of all asthma patients used >100 DDD short-acting ?-agonists… Continue reading